drugset / Trial / NCT01986335

Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center Trial

NCT01986335 ↗

Phase 3 Completed 600 enrolled PT Bio Farma
RandomizedParallel-groupDouble-blindPrevention

Summary

The objectives of this study were to analyze the immunogenicity and reactogenicity of DTP/HB/Hib (Bio Farma) combination vaccine.

Timeline

Start
2012-08
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DTP/HB/Hib Vaccine Vaccine — —

Indications

No indication recorded.